National Pharmaceuticals (NFRM) has entered into an agreement with Globe Laboratories to become an exclusive partner to develop its drugs to the final phase of development.
Subscribe to our email newsletter
Globe Laboratories brings to the partnership its expertise in biopharmaceutical drugs manufacturing and development, and experience in late stage drug development.
National Pharmaceuticals president and CEO Elaine Affleck said the company does not need to set up its own laboratories and hire technical personnel to carry out its drug development at present.
"While NFRM is responsible with the costs associated with drug development and approval process of its drugs, this highly qualified team can shorten the time needed to bring our drugs to the market successfully," Affleck said.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.